SCHEMBL17355692

SCHEMBL17355692

Cc1cc(OS(=O)(=O)c2ccc(F)cc2)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.47
CA12 O43570 2/20 0.46
CA2 P00918 2/20 0.46
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ENPP1 P22413 4/20 0.45
ENPP2 Q13822 3/20 0.45
MEN1 O00255 1/20 0.44
SLC22A12 Q96S37 1/20 0.42
CNR2 P34972 1/20 0.42
ENPP3 O14638 4/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
ALPL P05186 1/20 0.41
ALPI P09923 1/20 0.41
SOS1 Q07889 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17355689 0.90 KMT2A (0.55) CA12CA2KMT2ATDP1L3MBTL1
SCHEMBL17355694 0.87 KMT2A (0.46) KMT2ATDP1L3MBTL1LMNAHTT
SCHEMBL17355680 0.87 TDP1 (0.56) CA12CA2KMT2ATDP1L3MBTL1
SCHEMBL17355687 0.85 ENPP3 (0.48) CA2KMT2ATDP1L3MBTL1LMNA
SCHEMBL22558454 0.80 AKR1C3 (0.55) AKR1C3CA12CA2KMT2AHTT
SCHEMBL4126119 0.80 AKR1C3 (0.55) AKR1C3CA12CA2KMT2AHTT
SCHEMBL17355696 0.79 CA1 (0.46) CA2KMT2ALMNASMN1; SMN2MEN1
SCHEMBL926461 0.79 CA12 (0.51) AKR1C3CA12CA2KMT2ATDP1
SCHEMBL17356449 0.78 SLC22A12 (0.44) AKR1C3CA12CA2TDP1L3MBTL1
SCHEMBL7247499 0.78 ALDH1A1 (0.49) CA12CA2KMT2ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE HCN2, SCO2, HCN1 AKR1C3 773/4885CA12 2756/4885CA2 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.